Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Maravai Lifesciences Holdings (MRVI) Return on Equity (2021 - 2025)

Historic Return on Equity for Maravai Lifesciences Holdings (MRVI) over the last 5 years, with Q3 2025 value amounting to 0.48%.

  • Maravai Lifesciences Holdings' Return on Equity fell 100.0% to 0.48% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.48%, marking a year-over-year decrease of 100.0%. This contributed to the annual value of 0.38% for FY2024, which is 2200.0% down from last year.
  • Per Maravai Lifesciences Holdings' latest filing, its Return on Equity stood at 0.48% for Q3 2025, which was down 100.0% from 0.68% recorded in Q2 2025.
  • Over the past 5 years, Maravai Lifesciences Holdings' Return on Equity peaked at 0.97% during Q2 2021, and registered a low of 0.68% during Q2 2025.
  • Over the past 5 years, Maravai Lifesciences Holdings' median Return on Equity value was 0.19% (recorded in 2023), while the average stood at 0.21%.
  • Its Return on Equity has fluctuated over the past 5 years, first surged by 1900bps in 2022, then plummeted by -7300bps in 2023.
  • Maravai Lifesciences Holdings' Return on Equity (Quarter) stood at 0.94% in 2021, then crashed by -40bps to 0.56% in 2022, then plummeted by -129bps to 0.16% in 2023, then crashed by -165bps to 0.44% in 2024, then dropped by -9bps to 0.48% in 2025.
  • Its Return on Equity stands at 0.48% for Q3 2025, versus 0.68% for Q2 2025 and 0.52% for Q1 2025.